Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Selinexor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05530421
What this trial is testing

Selinexor, Venetoclax, and Dexamethasone (XVenD) in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
University of Miami 33
Large-scale testing (Phase 3)Study completedNCT03555422
What this trial is testing

Maintenance With Selinexor/Placebo After Combination Chemotherapy in Participants With Endometrial Cancer [SIENDO]

Who this might be right for
Endometrial Cancer
Karyopharm Therapeutics Inc 263
Testing effectiveness (Phase 2)Active Not RecruitingNCT02835222
What this trial is testing

Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients

Who this might be right for
Untreated Adult Acute Myeloid Leukemia
Wake Forest University Health Sciences 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT07779031
What this trial is testing

A Single-Arm, Open Phase I Clinical Study of Selinexor in Combination With Azacitidine for the Treatment of High-Risk AML/MDS Patients After Allo-HSCT

Who this might be right for
Acute Myeloid Leukaemia (AML)MDS (Myelodysplastic Syndrome)
Liping Dou 58
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07574528
What this trial is testing

A Phase II Study of Sintilimab, Pegaspargase and Selinexor Followed by Radiotherapy in Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma

Who this might be right for
NKTCL
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Ended earlyNCT03071276
What this trial is testing

Selinexor in Combination With Fludarabine and Cytarabine in Patients With Refractory or Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
St. Jude Children's Research Hospital 37
Testing effectiveness (Phase 2)Looking for participantsNCT07479979
What this trial is testing

Study of Selinexor With Carfilzomib, Isatuximab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Relapse Multiple MyelomaRefractory Multiple Myeloma
Natalie Callander 62
Large-scale testing (Phase 3)Active Not RecruitingNCT06158841
What this trial is testing

Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 421
Testing effectiveness (Phase 2)Looking for participantsNCT05099003
What this trial is testing

The Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Who this might be right for
Malignant Glioma
National Cancer Institute (NCI) 132
Testing effectiveness (Phase 2)Looking for participantsNCT02343042
What this trial is testing

Selinexor and Backbone Treatments of Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Karyopharm Therapeutics Inc 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06900088
What this trial is testing

Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myelomonocytic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Looking for participantsNCT05333458
What this trial is testing

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

Who this might be right for
Advanced Alveolar Soft Part SarcomaAdvanced Soft Tissue SarcomaMetastatic Alveolar Soft Part Sarcoma+2 more
National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT05983276
What this trial is testing

Decitabine and Selinexor in Combination to Reverse Drug Resistance With Standard Chemotherapy in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Loyola University 40
Testing effectiveness (Phase 2)Study completedNCT06212596
What this trial is testing

Selinexor, Cyclophosphamide and Prednisone in Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
University of Leeds 66
Early research (Phase 1)Study completedNCT02485535
What this trial is testing

Selinexor in Treating Patients With Intermediate- and High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome After Transplant

Who this might be right for
Acute Myeloid Leukemiade Novo Myelodysplastic SyndromeMyelodysplastic Syndrome+2 more
University of Chicago 12
Testing effectiveness (Phase 2)WithdrawnNCT02536495
What this trial is testing

Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer

Who this might be right for
Recurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma
Erin Bertino
Large-scale testing (Phase 3)Study completedNCT02606461
What this trial is testing

Selinexor in Advanced Liposarcoma

Who this might be right for
Dedifferentiated Liposarcoma
Karyopharm Therapeutics Inc 342
Testing effectiveness (Phase 2)Active Not RecruitingNCT03589222
What this trial is testing

SELIBORDARA: Selinexor, Bortezomib and Daratumumab in Multiple Myeloma

Who this might be right for
Refractory Multiple Myeloma
PETHEMA Foundation 62
Testing effectiveness (Phase 2)Study completedNCT02780609
What this trial is testing

Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
H. Lee Moffitt Cancer Center and Research Institute 22
Not applicableUnknownNCT05805072
What this trial is testing

Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients

Who this might be right for
Relapsed/Refractory AML
The First Affiliated Hospital of Soochow University 20
Next Page